LDLR and atherosclerosis: Allicin can be a good candidate drug for atherosclerosis and reduce plasma lipid concentrations and low-density lipoprotein receptor (LDLR), as it show the efficacy through modification and inhibition of LDL uptake, degradation by macrophages [24, 25].